Cite
253Effect of i.v. ferric carboxymaltose iron therapy on symptoms and functional status in iron-deficient patients with HFrEF and renal dysfunction: An individual patient data meta-analysis
MLA
Bernard Roubert, et al. “253Effect of i.v. Ferric Carboxymaltose Iron Therapy on Symptoms and Functional Status in Iron-Deficient Patients with HFrEF and Renal Dysfunction: An Individual Patient Data Meta-Analysis.” European Heart Journal, vol. 38, Aug. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4c2ce6748c2071306a6ac0b4235aba7f&authtype=sso&custid=ns315887.
APA
Bernard Roubert, S.D. Anker, Iain C. Macdougall, G. Filippatos, D. J. Van Veldhuisen, P. Ponikowski, Michael Böhm, & J. Comin Colet. (2017). 253Effect of i.v. ferric carboxymaltose iron therapy on symptoms and functional status in iron-deficient patients with HFrEF and renal dysfunction: An individual patient data meta-analysis. European Heart Journal, 38.
Chicago
Bernard Roubert, S.D. Anker, Iain C. Macdougall, G. Filippatos, D. J. Van Veldhuisen, P. Ponikowski, Michael Böhm, and J. Comin Colet. 2017. “253Effect of i.v. Ferric Carboxymaltose Iron Therapy on Symptoms and Functional Status in Iron-Deficient Patients with HFrEF and Renal Dysfunction: An Individual Patient Data Meta-Analysis.” European Heart Journal 38 (August). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4c2ce6748c2071306a6ac0b4235aba7f&authtype=sso&custid=ns315887.